CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates how GLP-1 receptor agonists may influence the regression of atherosclerosis, a leading cause of cardiovascular diseases. It focuses on understanding the cellular mechanisms involved, particularly the role of specific cell types in vascular inflammation.
Cardiovascular diseases (CVD) are highly prevalent in Europe, causing more than 3.9 million deaths yearly.
Atherosclerosis, a chronic inflammatory disease of the arterial wall, is the main underlying cause of CVD.
Available strategies to treat and prevent atherosclerosis remain suboptimal, therefore, better understanding of its regulatory mechanisms is required to design new approaches to treat this inflammatory disease.
Recent cardiovascular outcome trials demonstrated that GLP-1R agonists (GL…
UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
